Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedA new Locations section is added with state entries (CA, HI, LA, MD, MA, MO, NY, OH, TX, WA). The page revision is updated to v3.3.3 and previous state-specific location blocks are removed.SummaryDifference0.9%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now shows a new Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check48 days agoChange DetectedThe government funding and NIH operating status notice has been removed from the page. This is a minor housekeeping change that does not affect the study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedPosted results were added to the study page, including Results First Submitted: 2022-08-25 and Results First Posted: 2023-01-10. The Study Record Dates section and related results sections were updated accordingly.SummaryDifference0.3%

- Check91 days agoChange DetectedCore content updated with government funding status notice and operating status links, and version bumped from v3.1.0 to v3.2.0.SummaryDifference2%

- Check98 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.